Skip to main content
. 2022 Oct 26;12:17950. doi: 10.1038/s41598-022-22932-4

Table 2.

Mortality rates and risk according to risk factors and risk group, unadjusted and adjusted (Cox regression).

Variable Group N Mortality rate (number of events per 100 person years, 95 CI) HR (univariate analysis; 95 CI) HR (multivariate analysis; 95 CI)
Sex Female 16,246 0.90 (0.82, 0.98) – (Reference) – (Reference)
Male 20,057 0.97 (0.9, 1.05) 1.08 (0.96–1.22) 1.20 (1.06–1.36)
Age (years) 18–49 25,762 0.22 (0.19, 0.25)
50–59 5121 1.22 (1.07, 1.39) 5.51 (4.53–6.71) 2.59 (2.04–3.29)
60–69 3584 2.73 (2.45, 3.04) 12.32 (10.30–14.74) 3.97 (3.11–5.27)
≥ 70 1836 6.98 (6.33, 7.69) 31.63 (26.59–37.62) 6.98 (5.14–9.48)
BMI (kg/m2) < 18.5 485 2.24 (1.61, 3.06) 3.09 (2.16, 4.42) 3.96 (2.76, 5.70)
18.5–24.9 13,504 0.85 (0.77, 0.94) 1.16 (1.00, 1.36) 1.23 (1.05, 1.44)
25.0–29.9 10,719 0.73 (0.65, 0.82)
30.0–34.9 3639 1.10 (0.93, 1.3) 1.51 (1.23, 1.85) 1.24 (1.00, 1.52)
35.0–39.9 919 1.08 (0.77, 1.48) 1.48 (1.03, 2.12) 1.19 (0.83, 1.72)
≥ 40 293 1.37 (0.8, 2.2) 1.87 (1.07, 3.27) 1.45 (0.82, 2.54)
Missing 6744
HbA1c (%) < 7.0% 8408 0.92 (0.82, 1.04) 1.16 (0.97, 1.38) 1.23 (1.03, 1.48)
7.0–7.8% 8692 0.8 (0.7, 0.9)
7.8–8.8% 10,053 0.93 (0.83, 1.04) 1.17 (0.98, 1.38) 1.18 (1.00, 1.40)
8.8–9.6% 4230 0.99 (0.84, 1.16) 1.25 (1.01, 1,54) 1.40 (1.13, 1.73)
≥ 9.6% 3995 1.10 (0.94, 1.29) 1.39 (1.13, 1.72) 1.72 (1.39, 2.13)
Missing 925
Diastolic blood pressure (mmHg) < 60 1211 2.78 (2.31, 3.33) 2.44 (1.96, 3.04) 1.10 (0.88, 1.38)
60–69 7510 1.14 (1.02, 1.28)
70–79 13,914 0.78 (0.71, 0.87) 0.69 (0.59, 0.80) 1.10 (0.94, 1.29)
80–89 9377 0.65 (0.57, 0.74) 0.57 (0.48, 0.68) 1.08 (0.89, 1.30)
90–99 1427 0.85 (0.63, 1.14) 0.75 (0.54, 1.04) 1.62 (1.14, 2.31)
100–109 217 1.26 (0.67, 2.21) 1.11 (0.57, 2.16) 2.14 (1.07, 4.29)
≥ 110 29 3.42 (1.24, 8.23) 3.02 (0.97, 9.42) 2.92 (0.91, 9.35)
Missing 2618
Systolic blood pressure (mmHg) < 110 3047 0.77 (0.62, 0.96) 0.81 (0.63, 1.05) 1.82 (1.38, 2.38)
110–119 6525 0.57 (0.48, 0.68) 0.60 (0.48, 0.75) 1.31 (1.05, 1.64)
120–129 10,403 0.59 (0.52, 0.67) 0.62 (0.51, 0.74) 1.00 (0.83, 1.21)
130–139 7611 0.96 (0.84, 1.08)
140–149 3755 1.47 (1.27, 1.69) 1.54 (1.27, 1.86) 1.02 (0.84, 1.23)
150–159 1351 1.80 (1.45, 2.21) 1.88 (1.46, 2.42) 0.93 (0.72, 1.20)
≥ 160 1036 3.07 (2.54, 3.69) 3.23 (2.57, 4.07) 1.19 (0.93, 1.53)
Missing 2575
History of CVD No 33,130 0.51 (0.47, 0.56)
Yes 3173 5.60 (5.15, 6.07) 10.91 (9.71–12.26) 1.91 (1.66–2.20)
History of heart failure No 35,394 0.71 (0.67, 0.76)
Yes 909 11.12 (9.91, 12.44) 15.72 (13.75–17.97) 2.06 (1.76–2.40)
Albuminuria stage Normal 24,419 0.48 (0.43, 0.53)
Mild 976 1.21 (0.9, 1.61) 2.53 (1.84–3.50) 1.26 (0.91–1.74)
Microalbuminuria 2966 2.39 (2.1, 2.7]) 5.00 (4.25–5.87) 1.76 (1.48–2.09)
Macroalbuminuria 1524 5.14 (4.54, 5.79) 10.80 (9.22–12.65) 2.35 (1.92–2.87)
Missing 6418
eGFR stage G1 18,166 0.38 (0.33, 0.43)
G2 9641 0.87 (0.77, 0.97) 2.28 (1.92–2.71) 0.90 (0.75–1.09)
G3 1977 4.40 (3.92, 4.93) 11.62 (9.77–13.83) 1.47 (1.20–1.80)
G4 368 9.11 (7.51, 10.98) 24.22 (19.17–30.60) 2.71 (2.06–3.57)
G5 236 11.42 (9.11, 14.14) 30.53 (23.53–39.63) 3.81 (2.81–5.17)
Missing 5915

*Denotes the reference group.